Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Establishment Labs Holdings Inc. (ESTA : NSDQ)
 
 • Company Description   
Establishment Labs Holdings Inc. is a medical technology company. It focuses on designing, developing, manufacturing and marketing portfolio of silicone gel-filled breast implants ae well as body shaping implants. The company's brand consists of Motiva Implants(R) and MotivaImagine (R) platform. Its technologies portfolio includes Divina 3D Simulation System(R), Puregraft and MotivaImagine Centers (R). Establishment Labs Holdings Inc. is based in NEW YORK.

Number of Employees: 746

 
 • Price / Volume Information   
Yesterday's Closing Price: $56.87 Daily Weekly Monthly
20 Day Moving Average: 273,942 shares
Shares Outstanding: 24.20 (millions)
Market Capitalization: $1,376.13 (millions)
Beta: 1.08
52 Week High: $93.80
52 Week Low: $46.93
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -28.07% -23.80%
12 Week -8.88% -0.44%
Year To Date -15.86% 1.74%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
Building B15 and 25 Coyol Free Zone
-
Alajuela,G2 -
-
ph: 506 2434 2400
fax: -
ir@establishmentlabs.com http://www.establishmentlabs.com
 
 • General Corporate Information   
Officers
Juan Jose Chacon Quiros - Chief Executive Officer and Director
Nicholas Lewin - Chairman of the Board of Directors
Rajbir S. Denhoy - Chief Financial Officer
Lisa N. Colleran - Director
Dennis Condon - Director

Peer Information
Establishment Labs Holdings Inc. (CHCR)
Establishment Labs Holdings Inc. (ESRX)
Establishment Labs Holdings Inc. (MYDP)
Establishment Labs Holdings Inc. (GBCS)
Establishment Labs Holdings Inc. (LAXAF)
Establishment Labs Holdings Inc. (IPCM)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: Medical Services
Sector: Medical
CUSIP: G31249108
SIC: 3842
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/22
Next Expected EPS Date: 08/04/22
Share - Related Items
Shares Outstanding: 24.20
Most Recent Split Date: (:1)
Beta: 1.08
Market Capitalization: $1,376.13 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $-0.42 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $-1.31 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 3.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/04/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 28.77
Price/Cash Flow: -
Price / Sales: 10.21
EPS Growth
vs. Year Ago Period: 17.24%
vs. Previous Quarter: 59.32%
Sales Growth
vs. Year Ago Period: 26.75%
vs. Previous Quarter: 8.89%
ROE
03/31/22 - -70.10
12/31/21 - -64.87
09/30/21 - -46.91
ROA
03/31/22 - -27.60
12/31/21 - -27.78
09/30/21 - -21.40
Current Ratio
03/31/22 - 3.01
12/31/21 - 3.55
09/30/21 - 4.10
Quick Ratio
03/31/22 - 2.23
12/31/21 - 2.66
09/30/21 - 3.22
Operating Margin
03/31/22 - -29.77
12/31/21 - -32.47
09/30/21 - -27.54
Net Margin
03/31/22 - -29.77
12/31/21 - -32.47
09/30/21 - -27.54
Pre-Tax Margin
03/31/22 - -28.53
12/31/21 - -31.35
09/30/21 - -27.43
Book Value
03/31/22 - 1.98
12/31/21 - 2.11
09/30/21 - 2.59
Inventory Turnover
03/31/22 - 1.66
12/31/21 - 1.63
09/30/21 - 1.77
Debt-to-Equity
03/31/22 - 1.10
12/31/21 - 1.02
09/30/21 - 0.83
Debt-to-Capital
03/31/22 - 52.32
12/31/21 - 50.57
09/30/21 - 45.47
 

Powered by Zacks Investment Research ©